Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties ; volume:9 ; number:1 ; day:7 ; month:11 ; year:2023 ; pages:1-9 ; date:12.2023
International Journal of Retina and Vitreous ; 9, Heft 1 (7.11.2023), 1-9, 12.2023
- Urheber
-
Jørstad, Øystein Kalsnes
Foss, Stian
Gjølberg, Torleif Tollefsrud
Mester, Simone
Nyquist-Andersen, Mari
Sivertsen, Magne Sand
Fossum, Dag
Gleditsch, Espen
Moe, Morten Carstens
Andersen, Jan Terje
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-023-00507-3
- URN
-
urn:nbn:de:101:1-2024012409322403541053
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
30.01.20252025, 23:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jørstad, Øystein Kalsnes
- Foss, Stian
- Gjølberg, Torleif Tollefsrud
- Mester, Simone
- Nyquist-Andersen, Mari
- Sivertsen, Magne Sand
- Fossum, Dag
- Gleditsch, Espen
- Moe, Morten Carstens
- Andersen, Jan Terje
- SpringerLink (Online service)
Ähnliche Objekte (12)
Accuracy of intravitreal injection volume for aflibercept pre-filled syringe and BD Luer-Lok one-milliliter syringe
Air contamination, syringe contamination, and cross-contamination when using an automatic compounding device for sensitizing drugs
Compounding wines
Understanding compounding
Syringe
Polymeric Multivalent Fc Binding Peptides‐Fabricated Clinical Compounding Bispecific Antibody Potentiates Dual Immunotherapy Targeting PD1 and CTLA‐4
Pharmaceutical compounding and dispensing
Bispecific antibodies
Bispecific antibodies
Plastics compounding : equipment and processing
Potential Risks of Pharmacy Compounding
Caput V. De Syringe
Accuracy of intravitreal injection volume for aflibercept pre-filled syringe and BD Luer-Lok one-milliliter syringe
Air contamination, syringe contamination, and cross-contamination when using an automatic compounding device for sensitizing drugs
Compounding wines
Understanding compounding
Syringe
Polymeric Multivalent Fc Binding Peptides‐Fabricated Clinical Compounding Bispecific Antibody Potentiates Dual Immunotherapy Targeting PD1 and CTLA‐4
Pharmaceutical compounding and dispensing
Bispecific antibodies
Bispecific antibodies
Plastics compounding : equipment and processing
Potential Risks of Pharmacy Compounding
Caput V. De Syringe
Accuracy of intravitreal injection volume for aflibercept pre-filled syringe and BD Luer-Lok one-milliliter syringe
Air contamination, syringe contamination, and cross-contamination when using an automatic compounding device for sensitizing drugs
Compounding wines
Understanding compounding
Syringe
Polymeric Multivalent Fc Binding Peptides‐Fabricated Clinical Compounding Bispecific Antibody Potentiates Dual Immunotherapy Targeting PD1 and CTLA‐4
Pharmaceutical compounding and dispensing
Bispecific antibodies
Bispecific antibodies
Plastics compounding : equipment and processing
Potential Risks of Pharmacy Compounding